Specialty Pharmacy

Top news of the day from across the health care landscape.

System provides images deep within tumor tissue.

Concern persists among physicians who treat HIV-associated lymphoma with stem cell transplants due to the risk of harming the immune system.

Biodegradable polymer nanoparticles to deliver methotrexate may improve rheumatoid arthritis therapy.

The amount of cerebral microbleeds can influence the severity of physical and cognitive outcomes in MS patients.

Olive oil-based emulsion may help boost efficacy of bladder cancer therapy.

Gestational diabetes significantly increases the risk of developing type 2 diabetes within 5-years after giving birth.

Infants can quickly produce novel antibodies that protect against HIV.

The protein GlyRS helps modify proteins that cause cancer growth.

Neurodegeneration in Parkinson’s disease occurs from a failing mitochondrion.

Doxorubicin, all-trans retinoic acid, and entinostat significantly reduced triple-negative breast cancer tumors in mice.

Researchers examine how socialization institutes effect the way individuals in low income areas relate to HIV/AIDS after a natural disaster.

Findings improve the ability of providers to monitor the development of melanoma.

Anthrax toxin proteins are able to control tumor growth.

If cancerous tumors have an addiction to a gene, an inhibitor can be administered that can stop cell growth.

Postmenopausal patients with invasive ductal carcinomas had high levels of saturated fats.

Researchers find indicators of poor chemotherapy response.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week on Specialty Pharmacy Times.

Women older than age 65 face higher risk for several comorbidities from breast cancer treatment.

Recent advances and updates in oncology and cancer drug development.

Skin cells from diabetic foot ulcers could be reprogrammed to acquire properties of embryonic-like cells.

Specialty pharmacies may be able to better monitor comorbid conditions in psoriatic arthritis patients.

Children and adolescents with JIA are also likely to develop other autoimmune diseases beyond diabetes.

Individuals with primary immunodeficiency carry increased risk of developing a variety of cancers.

The drug eCF506 can selectively block the Src tyrosine kinase and stop the growth of breast cancer cells.

Larger waist circumference associated with an increased risk of aggressive prostate cancer.

The CRISPR system may revolutionize the treatment of a range of diseases.